Yossi Keret is CEO of Nanorobotics, a disruptive startup in biotech, where he leads management, fundraising, financing, business development, strategic negotiations, and other company activities. In addition, he is a board member of Wize Pharma. Prior to joining Nanorobotics, Yossi worked with high-tech, biotech, and cleantech companies reorganizing and preparing them for public or private fundraising. He is the former CEO and board member of Weebit Nano, and the former global CFO of the following companies: Eric Cohen Books & Burlington English, Daimler Financial Services, Pluristem, M.L.L. Software and Computer Industries.
Yossi’s accomplishments include leading a successful IPO in the Australian Stock Exchange as part of his CEO role; leading the successful development of ReRAM (memory) from Rice University to 40 Nano working cells; taking a major part in a successful Initial Public Offering (IPO) in NASDAQ; leading private equity raising (PIPE) for public companies; possessing in-depth familiarity with accounting regulations in Israel, US GAAP and IFRS; and taking a major part in M&A discussions and implementation. Yossi is a certified public accountant (CPA). He received his B.A. in economics and accounting from Haifa University in Haifa, Israel. He lives in Israel with his wife and three children.